Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
angiography, neurologic complications with
beta adrenergic blocker
carotid artery
CAT scan
CAT scan, abnormal
CAT scan, base of skull
catecholamine
cerebellar pontine angle tumor
cerebrovascular disease, surgical treatment of
chest x-ray
chest x-ray, abnormal
cranial nerve palsies, unilateral
cranial neuropathy, multiple
craniopharyngioma
depression
dopamine
dysphagia
embolization, therapeutic
flushing
foramen magnum, meningioma
glomus jugulare tumor
hemifacial atrophy
hoarseness
hypoglossal nerve paralysis
iatrogenic neurologic disorders
levetiracetam
malformation, vascular
malformation, vascular, cerebral
meningioma, sphenoid wing
MRI
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, skull bone changes
MRI, venography
nasopharyngeal carcinoma
neck pain
neoplasm, hormone producing
neoplasm, hormone producing, ectopic
neoplasm, metastatic to base of skull
neoplasm, skull base
neurologic disease, diagnoses of
neuroradiology, interventional
optic glioma
palpitations
pituitary, adenoma
recurrent laryngeal nerve paralysis
review article
schwannoma
Sicard-Collet syndrome
sternocleidomastoid wasting
tinnitus
tinnitus, pulsatile
tongue, fasciculations of
tongue, hemiatrophy of
treatment of neurologic disorder
trigeminal neuralgia
trigeminal neuralgia, bilateral
trigeminal neuralgia, treatment of
vagal neuropathy
vagus nerve, lesion of
vocal cord paralysis
Showing articles 800 to 850 of 3168 << Previous Next >>

Impact od Adjuvant Chemotherapy for Gliomatosis Cerebri
BMC Cancer 10:424, Kong, D-S.,et al, 2010

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Spinal Metastasis and Metastatic Disease to the Spine and Related Structures
eMedicine March, Tse,V., 2009

Limbic Encephalitis Associated With Antibodies to the NMDA Receptor in Hodgkin Lymphoma
Neurol 73:2039-2040, Zanid,M.S.,et al, 2009

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009

Autism
Lancet 374:1627-1638, Levy,S.,et al, 2009

Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

Leukodystrophies: Classification, Diagnosis, and Treatment
Neurologist 15:319-328, Costello,D.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Supratentorial Low-Grade Gliomas in Older Patients
Neurol 73:2093-2098, 2056, Kaloshi,G.,et al, 2009

Practice Parameter: Evaluation of the Child with Microcephaly (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 73:887-897, Ashwal,S.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Invited Article: An MRI-Based Approach to the Diagnosis of White Matter Disorders
Neurol 72:750-759, Shiffmann,R. &van der Knaap,M.S., 2009

Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009

Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Differential Diagnosis of Postpartum Headaches
Rev Mex Anest 32:Suppl1 S16-S23, MacArthur,A., 2009

Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke 40:2893-2898, Morris,J.G.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Treating Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation
NEJM 360:2730-2741, Pui,C.-H.,et al, 2009

Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009

Clinical Spectrum of Ataxia-Telangiectasia in Adulthood
Neurol 73:430-437, Verhagen,M.M.M.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Incidental Findings on Brain Magnetic Resonance Imaging: Systematic Review and Meta-analysis
BMJ 339:547-550, 522, Morris,Z.,et al, 2009

Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009

Subarachnoid Haemorrhage
BMJ 339:569-570, Hankey,G. &Nelson,M., 2009

Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
J Natl Cancer Inst 101:946-958, Armstrong,G.T.,et al, 2009

Meningeal Carcinomatosis and Uterine Carcinoma
Int J Gynecol Cancer 19:168-172, Asensio, N.,et al, 2009

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009

Paraneoplastic Extra Limbic Encephalitis Associated with Thymoma
ICVTS 9:755-756, Rizzardi,G.,et al, 2009

Plasmablastic Lymphoma: CNS Involvement, Coexistence of Other Malignancies, Possible Viral Etiology, and Dismal Outcome
Ann Hematol 88:351-358, Ustun, C.,et al, 2009

Scattered Cerebral Microbleeds Due to Cardiac Myxoma
Arch Neurol 66:796-797, Vanacker,P.,et al, 2009

Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009



Showing articles 800 to 850 of 3168 << Previous Next >>